Bookmark and Share

The Best Yielding Large Cap Healthcare Dividend Stocks

Large Capitalized Healthcare Dividend Stocks With Highest Yield Researched By Dividend Yield - Stock, Capital, Investment. It’s very important to know what yields are traded within a sector or industry in order to compare risks and premiums. I made a screen of the best yielding large capitalized healthcare stocks. 38 companies from the healthcare sector have a market capitalization over USD 10 billion and 29 of them pay dividends. The ten best yielding stocks come from the major drug manufacturing industry which is an unbeaten dividend paying industry despite the burdens of margin pressure due to patent losses and budget cuts from the public and insurance sector. All events lead to slowing growth. The second best dividend industry is the medical instruments and equipment industry.

Below the best yielding large caps is only one high yield and ten stocks yielding over three percent.


Here are the best yielding results:
(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

AstraZeneca (NYSE:AZN) has a market capitalization of $56.28 billion. The company employs 57,200 people, generates revenues of $33,591.00 million and has a net income of $10,016.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,792.00 million. Because of these figures, the EBITDA margin is 44.04 percent (operating margin 38.09 percent and the net profit margin finally 29.82 percent). 


Financial Analysis: The total debt representing 17.66 percent of the company’s assets and the total debt in relation to the equity amounts to 40.13 percent. Due to the financial situation, a return on equity of 42.98 percent was realized. Twelve trailing months earnings per share reached a value of $6.49. Last fiscal year, the company paid $2.80 in form of dividends to shareholders. 


Market Valuation: Here are the price ratios of the company: The P/E ratio is 6.82, P/S ratio 1.66 and P/B ratio 2.44. Dividend Yield: 6.38 percent. The beta ratio is 0.60.


Long-Term Stock History Chart Of AstraZeneca plc (ADR) (Click to enlarge)
Long-Term Dividends History of AstraZeneca plc (ADR) (AZN) (Click to enlarge)
Long-Term Dividend Yield History of AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)


GlaxoSmithKline (NYSE:GSK) has a market capitalization of $115.56 billion. The company employs 97,389 people, generates revenues of $44,452.20 million and has a net income of $8,858.95 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,945.63 million. Because of these figures, the EBITDA margin is 33.62 percent (operating margin 28.50 percent and the net profit margin finally 19.93 percent).


Financial Analysis: The total debt representing 36.27 percent of the company’s assets and the total debt in relation to the equity amounts to 185.52 percent. Due to the financial situation, a return on equity of 62.19 percent was realized. Twelve trailing months earnings per share reached a value of $3.25. Last fiscal year, the company paid $2.27 in form of dividends to shareholders. 


Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.34, P/S ratio 2.63 and P/B ratio 8.95. Dividend Yield: 4.92 percent. The beta ratio is 0.61.


Long-Term Stock History Chart Of GlaxoSmithKline plc (ADR) (Click to enlarge)
Long-Term Dividends History of GlaxoSmithKline plc (ADR) (GSK) (Click to enlarge)
Long-Term Dividend Yield History of GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge)


Eli Lilly & Co. (NYSE:LLY) has a market capitalization of $47.86 billion. The company employs 38,080 people, generates revenues of $24,286.50 million and has a net income of $4,347.70 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6,657.00 million. Because of these figures, the EBITDA margin is 27.41 percent (operating margin 22.03 percent and the net profit margin finally 17.90 percent). 


Financial Analysis: The total debt representing 20.76 percent of the company’s assets and the total debt in relation to the equity amounts to 51.60 percent. Due to the financial situation, a return on equity of 33.49 percent was realized. Twelve trailing months earnings per share reached a value of $3.86. Last fiscal year, the company paid $1.96 in form of dividends to shareholders. 


Market Valuation: Here are the price ratios of the company: The P/E ratio is 10.69, P/S ratio 1.98 and P/B ratio 3.54. Dividend Yield: 4.74 percent. The beta ratio is 0.68.


Long-Term Stock History Chart Of Eli Lilly & Co. (Click to enlarge)
Long-Term Dividends History of Eli Lilly & Co. (LLY) (Click to enlarge)
Long-Term Dividend Yield History of Eli Lilly & Co. (NYSE: LLY) (Click to enlarge)


Take a closer look at the full table of the best yielding large capitalized dividend stocks. The average price to earnings ratio (P/E ratio) amounts to 15.75 and forward P/E ratio is 11.56. The dividend yield has a value of 2.50 percent. Price to book ratio is 3.20 and price to sales ratio 2.39. The operating margin amounts to 19.64 percent.

Here is the full table with some fundamentals (TTM):

The Best Yielding Large Cap Healthcare Dividend Stocks (Click to enlarge)

Related stock ticker symbols:
AZN, GSK, LLY, SNY, NVS, MRK, BMY, PFE, JNJ, ABT, MDT, BAX, STJ, BDX, TEVA, AMGN, NVO, WLP, COV, AET, SYK, FMS, HUM, UNH, ZMH, TMO, SHPGY, AGN, CI


Selected Articles:

I am long JNJ, MDT, BDX, BAX. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.

For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.

No comments:

Post a Comment

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.